Did you catch our insightful webinar on Linking rational design and material-sparing strategies for enabled intermediates and their drug products? If not, or if you're looking for a concise recap of the key discussions, our new executive summary paper is here to help!
This paper dives into innovative approaches for tackling the challenge of poorly soluble APIs – a common hurdle in drug development. We explored how to efficiently design enabled formulations that enhance bioavailability and help you reach your target dosages. The webinar highlighted a smart, material-sparing process focused on developing spray-dried intermediates (SDIs) and their tablet formulations, using a real-world example to illustrate the process.
Inside this Executive Summary, you'll discover:
- Smart & sustainable techniques: Learn about Lonza's cutting-edge, material-sparing methods, including small-scale spray drying and insightful modeling tools, that help optimize your formulation from the start.
- Boost your drug's potential: Understand how our formulation development process is designed to enhance the bioavailability of your valuable APIs significantly.
- The power of synergy: Explore how understanding the compatibility between excipients and your drug substance, through advanced modeling, leads to robust and effective drug product formulations.